Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Plaque Psoriasis
Clinical trial NCT02601469 · COMPLETED
Trial details
- NCT number
- NCT02601469
- Sponsor
- Sun Pharmaceutical Industries, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-04
- Primary completion
- 2016-12-29
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.